Startups
Senseye, Inc. (Mental Health)
Austin, Texas, United States
Senseye, Inc. is an Austin-based neurotechnology company developing an investigational smartphone platform for objective mental health assessment, initially focused on PTSD. Its software uses computer vision, machine learning and ocular biomarkers such as pupil dynamics and eye movements. The company states that its device is for investigational use and its performance characteristics have not been established; clinical research and planned indications do not establish FDA marketing approval. Founder and CEO David Zakariaie leads the company. The current public directory names five leadership professionals and four medical advisers. SEC filings identify this Delaware corporation as CIK1656387, organized in2015, initially inLosAngeles and laterAustin. Topcon Healthcare announced a strategic investment inSeptember2025, and Capital Factory identifies it as a Texas FundII holding. It is separate from the industrial predictive-maintenance company Senseye at senseye.io; none of the industrial company funding is assigned here.
Team
 Ali TafreshiBoard Director (reported October 2025) |
 Allison FabianSVP, Strategy and Operations |
 Barbara RothbaumMedical Advisory Board Member |
 Brad StrasserVP, Clinical, Quality & Regulatory |
 Caitlin LimoncielloDirector, Research |
 Charles NemeroffChairperson, Medical Advisory Board |
 David DurrantSVP, Development |
 David ZakariaieCEO & Founder |
 Gordon DaughertyBoard Director (reported October 2025) |
Gregory EchtBoard Director (reported October 2025) |
 Kerry ResslerMedical Advisory Board Member |
 Paul SantosBoard Director (reported October 2025) |
 Steven BerkowitzMedical Advisory Board Member |